Sven Mahner

ORCID: 0000-0002-0640-129X · 40 papers in corpus
case-report 2021
Journal of ovarian research ·doi:10.1186/s13048-021-00839-4

BACKGROUND: For young borderline ovarian tumor (BOT) patients, preservation of the uterus was incorporated as an accepted option into treatment guidelines. For the endometrioid subtype (eBOT) however, adequate histological evaluation is cha…

other 2021
Histochemistry and cell biology ·doi:10.1007/s00418-021-02005-9

The vitamin D receptor (VDR) and aryl hydrocarbon receptor (AHR) are two nuclear receptors that exert their effects by binding with ligands and forming a molecular complex. These complexes translocate to the nucleus and activate the express…

case-report 2021
Clinical case reports ·doi:10.1002/ccr3.4039

Heterotopic pregnancy is a rare event in natural conception (1:30000). We describe a case of a 36-year-old nulliparous. She presented to our department in the 4 + 6 gestational week with two simultaneous pregnancies intrauterine and extraut…

observational 2020
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-020-03241-7

PURPOSE: Thyroid hormone receptors (THR) have manifold functions and are involved in the carcinogenesis of several tumor types. Within this study, we aimed to investigate the expression pattern (nuclear versus cytoplasmic) of the THR alpha …

review 2020
International journal of molecular sciences ·doi:10.3390/ijms21155175

Assisted reproductive technology (ART) has rapidly developed and is now widely practised worldwide. Both the characteristics of ART (handling gametes/embryos in vitro) and the infertility backgrounds of ART parents (such as infertility dise…

other 2020
International journal of molecular sciences ·doi:10.3390/ijms21124529

Prognostic factors are of great interest in patients with endometrial cancer. One potential factor could be the protein MSX1, a transcription repressor, that has an inhibitory effect on the cell cycle. For this study, endometrioid endometri…

other 2020
Histochemistry and cell biology ·doi:10.1007/s00418-020-01873-x

Several risk factors like obesity and hyperlipidemia were described for endometrial cancer. Here, the nuclear NAD-dependent histone-deacetylase Sirtuin1 (SIRT1) seems to be important. SIRT1 is also involved in cell regulatory mechanisms and…

other 2019
EBioMedicine ·doi:10.1016/j.ebiom.2019.02.027

BACKGROUND: We recently demonstrated the increased abundance of anti-trophoblast antibodies (ATAB) in sera of patients with unexplained recurrent miscarriages (uRM). Further, the ATAB-positive sera bound to JEG-3 human choriocarcinoma cells…

observational 2017
Oncology letters ·doi:10.3892/ol.2017.5969

17β-estradiol (E2) can contribute to the progression of epithelial ovarian cancer (EOC). Although the majority of patients with EOC are postmenopausal woman, when de novo estrogen production in the ovary has ceased, ovarian cancer cells rem…

observational 2017
Oncology letters ·doi:10.3892/ol.2017.6592

The present study aimed to identify differences in protein expression in cases of endometrioid endometrial cancer (EEC) with and without coexisting adenomyosis uteri (AM), and to evaluate the histopathological and prognostic distinctions. T…

lab-animal 2017
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4405-x

PURPOSE: The nuclear hormone receptor estrogen receptor α (ERα) is pivotal for numerous processes in the cell. As a transcription factor, it regulates eukaryotic gene expression and affects cellular proliferation and differentiation in targ…

observational 2017
Histochemistry and cell biology ·doi:10.1007/s00418-017-1616-y

Prostaglandin E2 (PGE2) is well described to be associated with both endometrial functions and disorders. The primary aim of this study was to explore the underlying mechanisms that affect the growth and function of endometrial epithelium a…

review 2017
International journal of molecular sciences ·doi:10.3390/ijms18081651

Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, includ…

diagnostic-accuracy 2013
BMC cancer ·doi:10.1186/1471-2407-13-178

BACKGROUND: The immune system is a key player in fighting cancer. Thus, we sought to identify a molecular 'immune response signature' indicating the presence of epithelial ovarian cancer (EOC) and to combine this with a serum protein biomar…

observational 2013
Journal of ovarian research ·doi:10.1186/1757-2215-6-48

BACKGROUND: Surgery is the cornerstone for clinical management of patients with borderline ovarian tumors (BOT). As these patients have an excellent overall prognosis, perioperative morbidity is the critical point for decision making when t…